An incredible achievement for nanomedicine was accomplished by Arizona State University scientists, in collaboration with researchers from the National Center for Nanoscience and...
read more
Breakthrough Therapy Designation
Cellular Destruct Code Could Revolutionize Oncology Treatments
Researchers from Northwestern Medicine have determined that every cell within the human body contains a “kill code” that gets triggered if it senses a cell is turning cancerous. Marcus...
read more
New Acute Myeloid Leukemia Treatment under FDA Review
Results of the recent QuANTUM-R study for Quizartinib have revealed a 24 percent improvement in survival rates compared to patients who received salvage chemotherapy, for cases of acute...
read more
Ovarian Cancer Treatment Might Soon Be Used By Prostate Patients
Rubraca, a drug initially designed to treat certain forms of ovarian cancer, has just received Breakthrough Therapy designation for advanced prostate malignancy. The drug was previously...
read more
First Treatment for Advanced Skin Cancer Approved
The FDA has just announced that Libtayo is now officially the first and only form of treatment for patients with cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who do...
read more
New TRK Inhibitor Shows Effectiveness in Treating Advanced Thyroid Cancer
Presented at the most recent Annual Meeting of the American Thyroid Association (ATA) in Washington, Larotrectinib has drawn a lot of attention by becoming the latest form of therapy for...
read more
